Individuals with two HNPCC-associated cancers a including synchronous and metachronous colorectal cancers or associated extracolonic cancers Individuals with colorectal cancer and a first-degree ...

Chaoyuan Kuang, MD, PhD, Co-Leader, GI Clinical and Translational Research, at Montefiore Einstein Comprehensive Cancer Center, and Othon Wiltz, MD, Colon and Rectal Surgeon, for Montefiore Einstein ...

Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks.

According to Cologuard, made by Wisconsin-based Exact Sciences, there are three primary reasons why you may receive a testing ...

This article is brought to you by Blue Cross and Blue Shield of Louisiana. Colon cancer has become more predominant across the nation in recent years, with the American Cancer Society estimating that ...

Fecal occult blood testing, a patient-administered test that is much less expensive than a colonoscopy, is a valid option for early detection of colon cancer, according to a report in the Canadian ...

(Reuters Health) - People may be more likely to get colorectal cancer screenings when doctors let them choose what type of test to have, a U.S. study suggests. Researchers focused on two widely used ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

As moms, we're constantly vigilant about our family's health, but there's a concerning trend that deserves our attention: colon cancer rates are surging among younger adults ( that's you and me, ...

Data support routine use of circulating tumor DNA testing in management of stage III colon cancer patients Tumor fraction analysis provides further insights for patient management in patients with ...

Researchers at the University of California, Irvine have developed a 3D human colon model integrated with bioelectronics to aid in colorectal cancer research and drug discovery. The "3D in vivo ...